View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Moody's announces completion of a periodic review of ratings of DuPont...

Moody's Ratings has completed a periodic review of the ratings of DuPont de Nemours, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 1 April 2024 in which Moody's reassessed the appropriateness of the ratings in the context of...

Moody's places Chemours' ratings under review for downgrade

Moody's Investors Service (Moody's) has placed under review for downgrade The Chemours Company's ("Chemours") Ba3 corporate family rating ("CFR"), Ba3-PD probability of default rating ("PDR"), Ba1 rating on its senior secured credit facilities, and the B1 rating on its senior unsecured notes. Previo...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Chemours Company, (The): Update to credit analysis

Our credit view reflects weakening metrics and a difficult macroeconomic environment as well as significant environmental liabilities related to PFAS.

Valens Research
  • Valens Research

CC - Valens Credit Report - 2023 11 20

Credit markets are grossly overstating CC's credit risk with a YTW of 9.084% relative to an Intrinsic YTW of 6.454%, while CDS markets are materially overstating credit risk with a CDS of 355bps relative to an Intrinsic CDS of 180bps. Furthermore, Moody's is overstating the company's fundamental credit risk, with its speculative Ba3 credit rating three notches lower than Valens' XO (Baa3) credit rating. Incentives Dictate Behavior™ analysis highlights mostly positive signals for creditors. CC's...

Valens Research
  • Valens Research

Valens Credit Weekly Insights - 2023 08 16

Valens Credit Research team highlights CC, which has a compelling bond offering that we believe the market is currently mispricing, with strong fundamentals, favorable management alignment, and an actionable trade.

Valens Research
  • Valens Research

CC - Valens Credit Report - 2023 08 14

Credit markets are materially overstating CC's credit risk with a YTW of 7.737% relative to an Intrinsic YTW of 5.716%, while CDS markets are overstating credit risk with a CDS of 255bps relative to an Intrinsic CDS of 157bps. Furthermore, Moody's is overstating the company's fundamental credit risk, with it speculative Ba3 credit rating three notches lower than Valens' XO (Baa3) credit rating. Incentives Dictate Behavior™ analysis highlights mostly positive signals for creditors. CC's compensa...

Moody's assigns Ba1 to Chemours' term loans; outlook stable

Moody's Investors Service (Moody's) has assigned a Ba1 rating to The Chemours Company's ("Chemours") upsized and amended and extended $960 million Senior Secured Term Loan B3 due 2028 and €515 million Senior Secured Term Loan B3 due 2028. Proceeds from the issuance will be used to repay Chemours' ex...

DuPont de Nemours, Inc.: Update to credit profile after PFAS settlemen...

Our credit view of this issuer reflects its good margins, growth and free cash flow, somewhat offset by event risk related to acquisitions and PFAS settlements.

Chemours Co: 2 directors

Two Directors at Chemours Co bought/sold after exercising options 12,786 shares at between 32.300USD and 32.630USD. The significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the c...

The Chemours Company - March 2023 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Valens Research
  • Valens Research

CC - Valens Credit Report - 2023 05 09

Credit markets are grossly overstating CC's credit risk with a YTW of 8.024% relative to an Intrinsic YTW of 5.184%, while CDS markets are materially overstating credit risk with a CDS of 363bps relative to an Intrinsic CDS of 172bps. Furthermore, Moody's is overstating the company's fundamental credit risk, with it speculative Ba3 credit rating three notches lower than Valens' XO (Baa3) credit rating. Incentive Dictate Behavior™ analysis highlights mostly positive signals for creditors. CC's c...

The Chemours Company - December 2022 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Valens Research
  • Valens Research

CC - Valens Credit Report - 2023 03 06

Credit markets are grossly overstating CC's credit risk with a YTW of 8.420% relative to an Intrinsic YTW of 5.720%, while CDS markets are materially overstating credit risk with a CDS of 389bps relative to an Intrinsic CDS of 156bps. Furthermore, Moody's is overstating the company's fundamental credit risk, with it speculative Ba3 credit rating three notches lower than Valens' XO (Baa3) credit rating. Incentive Dictate Behavior™ analysis highlights mostly positive signals for creditors. CC's c...

Valens Research
  • Valens Research

Valens Credit Weekly Insights - 2022 12 14

Valens Credit Research team highlights CC, which has a compelling bond offering that we believe the market is currently mispricing, with strong fundamentals, favorable management alignment, and an actionable trade.

E.I. du Pont de Nemours and Company: Updated Credit Analysis Following...

Our credit view of this issuer reflects its leading market position, against its intense competition.

Valens Research
  • Valens Research

CC - Valens Credit Report - 2022 11 30

Credit markets are grossly overstating CC's credit risk with a YTW of 7.749% and a CDS of 379bps, relative to an Intrinsic YTW of 4.320% and an Intrinsic CDS of 154bps. Furthermore, Moody's is materially overstating the company's fundamental credit risk, with its speculative Ba3 credit rating five notches lower than Valens' IG4+ (Baa1) credit rating. Incentive Dictate Behavior™ analysis highlights mostly positive signals for creditors. CC's compensation framework incentivizes management to impr...

The Chemours Company - September 2022 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Moody's affirms Corteva's A3 ratings

Moody's Investors Service ("Moody's") affirmed the A3 Issuer rating, A3 Senior Unsecured Notes and Prime-2 ratings of E.I. du Pont de Nemours and Company (d/b/a Corteva Agriscience; "Corteva") reflecting its leading positions in seeds and agricultural chemicals, strong credit metrics and a managemen...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch